paper-with-me

Papers

GraphIX: Graph-based In silico XAI(explainable artificial intelligence) for drug repositioning from biopharmaceutical network

2022-12-21 · Atsuko Takagi, Mayumi Kamada, Eri Hamatani, Ryosuke Kojima, Yasushi Okuno

Drug repositioning holds great promise because it can reduce the time and cost of new drug development. While drug repositioning can omit various R&D processes, confirming pharmacological effects on biomolecules is essential for application to new diseases. Biomedical explainability in a drug repositioning model can support appropriate insights in subsequent in-depth studies. However, the validity of the XAI methodology is still under debate, and the effectiveness of XAI in drug repositioning prediction applications remains unclear. In this study, we propose GraphIX, an explainable drug repositioning framework using biological networks, and quantitatively evaluate its explainability. GraphIX first learns the network weights and node features using a graph neural network from known drug indication and knowledge graph that consists of three types of nodes (but not given node type information): disease, drug, and protein. Analysis of the post-learning features showed that node types that were not known to the model beforehand are distinguished through the learning process based on the graph structure. From the learned weights and features, GraphIX then predicts the disease-drug association and calculates the contribution values of the nodes located in the neighborhood of the predicted disease and drug. We hypothesized that the neighboring protein node to which the model gave a high contribution is important in understanding the actual pharmacological effects. Quantitative evaluation of the validity of protein nodes' contribution using a real-world database showed that the high contribution proteins shown by GraphIX are reasonable as a mechanism of drug action. GraphIX is a framework for evidence-based drug discovery that can present to users new disease-drug associations and identify the protein important for understanding its pharmacological effects from a large and complex knowledge base.

📄 PDF Abstract BibTeX arXiv:2212.10788

Code (0)

등록된 구현이 없습니다.

Tasks

Drug DiscoveryExplainable artificial intelligenceExplainable Artificial Intelligence (XAI)Graph Neural Network

Methods 이 논문이 사용한 방법론

Graph Neural Network 설명 없음

Similar Papers 제목 키워드 기반

GRAPHIX: A Pre-trained Graph Edit Model for Automated Program Repair

2021-09-29 · Thanh V Nguyen, Srinivasan H. Sengamedu

We present GRAPHIX, a pre-trained graph edit model for automatically detecting and fixing bugs and code quality issues in Java programs. Unlike sequence-to-sequence models, GRAPHIX leverages the abstract syntax structure…

Bug fixingDecoderProgram Repair

Graphix-T5: Mixing Pre-Trained Transformers with Graph-Aware Layers for Text-to-SQL Parsing

2023-01-18 · Jinyang Li, Binyuan Hui, Reynold Cheng, Bowen Qin 외

The task of text-to-SQL parsing, which aims at converting natural language questions into executable SQL queries, has garnered increasing attention in recent years, as it can assist end users in efficiently extracting vi…

Domain GeneralizationInductive BiasSemantic ParsingSQL Parsing+2

Comprehensible Artificial Intelligence on Knowledge Graphs: A survey

2024-04-04 · Simon Schramm, Christoph Wehner, Ute Schmid

Artificial Intelligence applications gradually move outside the safe walls of research labs and invade our daily lives. This is also true for Machine Learning methods on Knowledge Graphs, which has led to a steady increa…

Explainable artificial intelligenceInterpretable Machine LearningKnowledge GraphsSurvey

Accelerating Neural Networks for Large Language Models and Graph Processing with Silicon Photonics

2024-01-12 · Salma Afifi, Febin Sunny, Mahdi Nikdast, Sudeep Pasricha

In the rapidly evolving landscape of artificial intelligence, large language models (LLMs) and graph processing have emerged as transformative technologies for natural language processing (NLP), computer vision, and grap…

Artificial intelligence and the future of diagnostic and therapeutic radiopharmaceutical development: in Silico smart molecular design

2021-08-05 · Bahar Ataeinia, Pedram Heidari

Novel diagnostic and therapeutic radiopharmaceuticals are increasingly becoming a central part of personalized medicine. Continued innovation in the development of new radiopharmaceuticals is key to sustained growth and …

Diagnostic